These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15475829)

  • 21. [Beneficial effects of exogenous NO donors on morphologic changes induced by long-term administration of NO synthase blockers].
    Kristek F; Varga I
    Bratisl Lek Listy; 2001; 102(4):200-8. PubMed ID: 11723679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matúsková J; Lupták I; Pincíková T; Krajcírovicová K; Stvrtina S; Pomsár J; Pelouch V; Paulis L; Pechánová O
    Physiol Res; 2007; 56 Suppl 2():S25-S32. PubMed ID: 17824810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative study of myocardial microcirculation in arterial hypertension due to progressive inhibition of NO synthesis.
    Pereira LM; Mandarim-De-Lacerda CA
    Arq Bras Cardiol; 1999 Nov; 73(5):407-18. PubMed ID: 10887361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereology of the myocardium in hypertensive rats. Differences in relation to the time of inhibition of nitric oxide synthesis.
    Pereira LM; Vianna GM; Mandarim-de-Lacerda CA
    Virchows Arch; 1998 Oct; 433(4):369-73. PubMed ID: 9808439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.
    Darblade B; Batkai S; Caussé E; Gourdy P; Fouque MJ; Rami J; Arnal JF
    J Vasc Res; 2001; 38(3):266-75. PubMed ID: 11399899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertensive effects of oral administration of the aqueous extract of Solanum torvum fruits in L-NAME treated rats: evidence from in vivo and in vitro studies.
    Nguelefack TB; Mekhfi H; Dongmo AB; Dimo T; Watcho P; Zoheir J; Legssyer A; Kamanyi A; Ziyyat A
    J Ethnopharmacol; 2009 Jul; 124(3):592-9. PubMed ID: 19439171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentaerythrityl tetranitrate attenuates structural changes in conduit arteries evoked by long-term NO-synthase inhibition.
    Kristek F
    Br J Pharmacol; 2000 May; 130(2):450-6. PubMed ID: 10807685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
    Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of capillary growth in chronically stimulated rat muscles by N(G)-nitro-l-arginine, nitric oxide synthase inhibitor.
    Hudlická O; Brown MD; Silgram H
    Microvasc Res; 2000 Jan; 59(1):45-51. PubMed ID: 10625570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of inhibition of nitric oxide synthesis on the uptake of LDL and fibrinogen by arterial walls and other organs of the rat.
    Cardona-Sanclemente LE; Born GV
    Br J Pharmacol; 1995 Apr; 114(7):1490-4. PubMed ID: 7606353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
    Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GnRH and gonadotropin release is decreased in chronic nitric oxide deficiency.
    Barnes MJ; Lapanowski K; Rafols JA; Lawson DM; Dunbar JC
    Exp Biol Med (Maywood); 2001 Jul; 226(7):701-6. PubMed ID: 11444107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereology and immunohistochemistry of the myocardium in experimental hypertension: long-term and low-dosage administration of inhibitor of the nitric oxide synthesis.
    Gomes Pessanha M; Mandarim-de-Lacerda CA; Dumas Hahn M
    Pathobiology; 1999; 67(1):26-33. PubMed ID: 9873225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antihypertensive drugs on the myocardial microvessels in rats with nitric oxide blockade.
    Meirelles Pereira LM; Mandarim-de-Lacerda CA
    Pathol Res Pract; 2000; 196(5):305-11. PubMed ID: 10834387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
    Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE
    Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of nitric oxide in the regulation of spinal arteriolar tone.
    Ishikawa M; Sekizuka E; Krischek B; Sure U; Becker R; Bertalanffy H
    Neurosurgery; 2002 Feb; 50(2):371-7; discussion 377-8. PubMed ID: 11844273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats.
    Bell D; Zhao YY; Kelso EJ; McHenry EM; Rush LM; Lamont VM; Nicholls DP; McDermott BJ
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H904-14. PubMed ID: 16040721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Bernátová I; Pechánová O; Simko F
    Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo.
    Ma XL; Lopez BL; Christopher TA; Birenbaum DS; Vinten-Johansen J
    Am J Physiol; 1996 Nov; 271(5 Pt 2):H2045-51. PubMed ID: 8945924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.